With this fresh capital, the diagnostic chain plans to expand its Tier-1 footprint, beginning with Mumbai and scale its offerings across pathology, radiology, and nuclear medicine.
360 ONE Asset buys minority stake in House of Diagnostics
- Post author:gsc.ara2025
- Post published:January 24, 2026
- Post category:Blog
- Post comments:0 Comments

